Nursing and Midwifery Care Research Center, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Spiritual Health Research Center, School of Behavioral Sciences and Mental Health, University of Medical Sciences, Tehran, Iran.
BMC Psychiatry. 2023 Apr 1;23(1):220. doi: 10.1186/s12888-023-04715-x.
Family caregivers of dying cancer patients may suffer from grief experiences and bereavement complications. Previous studies have proposed some psycho-emotional interventions for the management of these complications. However, little attention has been given to family-based dignity intervention and expressive writing. This study was conducted to examine the effects of family-based dignity intervention and expressive writing, combined and alone, on anticipatory grief in family caregivers of dying cancer patients. This was a randomized controlled trial, in which 200 family caregivers of dying cancer patients were randomly assigned to four intervention groups: family-based dignity intervention (n = 50), expressive writing intervention (n = 50), combined family-based single dignity intervention and expressive writing (n = 50), and control group (n = 50). In three times (baseline, 1 week, and 2 weeks after the interventions), anticipatory grief was assessed by a 13-item anticipatory grief scale (AGS). Finally, we found a significant reducing effect of family-based dignity intervention on AGS (-8.12 ± 1.53 vs. -1.57 ± 1.52, P = 0.01) and its subscales including behavioral (-5.92 ± 0.97 vs. -2.17 ± 0.96, P = 0.04) and emotional (-2.38 ± 0.78 vs. 0.68 ± 0.77, P = 0.03) subscales compared to the control group. However, no significant effect was seen for expressive writing intervention and combined interventions of expressive writing and family-based dignity intervention. In conclusion, family-based dignity intervention may be a safe intervention for relieving anticipatory grief among family caregivers of dying cancer patients. Additional clinical trials are needed to confirm our findings. Registration number: IRCT20210111050010N1. Trial registration date:2021-02-06.
癌症晚期患者家属可能会经历悲伤体验和丧亲并发症。先前的研究已经提出了一些心理情绪干预措施来管理这些并发症。然而,对于基于家庭的尊严干预和表达性写作的关注较少。本研究旨在探讨基于家庭的尊严干预和表达性写作,单独和联合使用,对癌症晚期患者家属的预期性悲伤的影响。这是一项随机对照试验,将 200 名癌症晚期患者的家属随机分为四组干预组:基于家庭的尊严干预组(n=50)、表达性写作干预组(n=50)、基于家庭的单一尊严干预和表达性写作联合干预组(n=50)和对照组(n=50)。在三次时间点(基线、干预后 1 周和 2 周),使用 13 项预期性悲伤量表(AGS)评估预期性悲伤。最后,我们发现基于家庭的尊严干预对 AGS 有显著的降低作用(-8.12±1.53 与-1.57±1.52,P=0.01),并且其包括行为(-5.92±0.97 与-2.17±0.96,P=0.04)和情绪(-2.38±0.78 与 0.68±0.77,P=0.03)亚量表与对照组相比。然而,表达性写作干预和表达性写作与基于家庭的尊严干预联合干预没有显著效果。总之,基于家庭的尊严干预可能是缓解癌症晚期患者家属预期性悲伤的一种安全干预措施。需要进一步的临床试验来证实我们的发现。注册号:IRCT20210111050010N1。试验注册日期:2021 年 2 月 6 日。